flexible. reliable. affordable.
We develop, produce and distribute reagents, instruments and software for immunological diagnostics and research applications.
Our products allow flexible, reliable and affordable sensitization profiling of each patient.
Where it all starts!
In the beginning there was a vision to improve and modernize immunodiagnostics. Scientists - like our founder Christian Harwanegg - always strive for disruptive innovation, so after more than a decade with leading companies in the field he decided to start his own enterprise in 2016.
Our goal was clear: The newly founded company MADx (MacroArray Diagnostics) offers an allergy test that is supposed to be better, more efficient and easier to use than the ones of the competition.
In addition, we wanted to offer the entire value chain from test material to evaluation, the necessary hardware and software to the cloud-based interpretation software RAVEN that always runs in real time.
A mammoth project ?
Without question, but worth the effort: for sure. Over the past 5 years, we have launched two generations of the ALEX - Allergy Explorer, which now tests for around 300 different allergens - in a single, non-invasive step.
Our panel covers nearly 100% of the world's relevant allergens.
We have developed proprietary hardware and software solutions that define new standards. We are constantly innovating and expanding our portfolio, as most recently with the FOX - Food Xplorer, a solution for the detection of IgG-mediated food intolerances.
We improve the diagnosis of immunological diseases through innovation.
We enable individualized and evidence-based medicine while directly and indirectly reducing costs for healthcare systems and improving patients' quality of life.
We develop, produce and distribute innovative and high quality products for in vitro diagnostics of immunological diseases.
Our customers are professional service providers in the field of medical diagnostics.
By using our products, we enable our customers to provide cost-efficient healthcare according to the latest scientific findings and with state-of-the-art technology.
Science @ MADx
We are dedicated to continuously drive evolution in immunodiagnostics, with a special focus on type I allergies.
An extensive academic collaboration network ensures the translation of the newest findings in basic research into our products. This mutually benefical exchange with the scientific communities from the Americas, Asia, Australia, and Europe resulted in a plethora of molecular allergens unique to the ALEX2 platform and the inclusion of a cross-reactive carbohydrate inhibitor in the standard ALEX2 test kits. Both features allow for a thorough and highly specific IgE profiling for a diverse range of allergic patients. This leads to a quicker route to fitting therapeutic options.
Furthermore, a quarter of our staff is dedicated to the research & development department. Assay developers, biochemists, chemists, and molecular biologists are essential parts of our team.
This science-oriented company philosophy gives MADx the edge in developing new applications for its patented nano-bead technology. The power of this approach is demonstrated here.
If you are interested in a scientific collaboration with MADx, write us
Our management team
CHRISTIAN HARWANEGGChief Executive Officer
Chief Executive Officer
GEORG MITTERERChief Operating Officer
Chief Operating Officer
FLORIAN SCHNABLChief Financial Officer
Chief Financial Officer
MARTINA AUMAYRHead of Research & Development
Head of Research & Development
PETER FORSTENLECHNERHead of Sales & Marketing
Head of Sales & Marketing
LAURA LANGEHead of Manufacturing & Lab services
Head of Manufacturing & Lab services
BIRGIT WEISSENBÖCKHead of Quality & Regulatory
Head of Quality & Regulatory